| Product NDC: | 25021-130 | 
| Proprietary Name: | Levofloxacin | 
| Non Proprietary Name: | levofloxacin | 
| Active Ingredient(s): | 25 mg/mL & nbsp; levofloxacin | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25021-130 | 
| Labeler Name: | Sagent Pharmaceuticals | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA200560 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120105 | 
| Package NDC: | 25021-130-20 | 
| Package Description: | 1 VIAL in 1 CARTON (25021-130-20) > 20 mL in 1 VIAL | 
| NDC Code | 25021-130-20 | 
| Proprietary Name | Levofloxacin | 
| Package Description | 1 VIAL in 1 CARTON (25021-130-20) > 20 mL in 1 VIAL | 
| Product NDC | 25021-130 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | levofloxacin | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20120105 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sagent Pharmaceuticals | 
| Substance Name | LEVOFLOXACIN | 
| Strength Number | 25 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes |